Enzymatically Inactive Procaspase 1 stabilizes the ASC Pyroptosome and Supports Pyroptosome Spreading during Cell Division-Reference-Cited by-同舟云学术

Enzymatically Inactive Procaspase 1 stabilizes the ASC Pyroptosome and Supports Pyroptosome Spreading during Cell Division

Published:2016-08 Issue:35 Volume:291 Page:18419-18429
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Stein Robert,Kapplusch Franz,Heymann Michael Christian,Russ Susanne,Staroske Wolfgang,Hedrich Christian Michael,Rösen-Wolff Angela,Hofmann Sigrun Ruth

Funder

Deutsche Forschungsgemeinschaft

Else Kröner-Fresenius-Stiftung

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference54 articles.

1. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β;Martinon;Mol. Cell,2002

2. Novel inflammasomes and type II diabetes, intestinal inflammation and psoriasis as newly inflammasome-related diseases;Heymann;J. Genet. Syndr. Gene Ther,2011

3. Inflammatory caspases: key regulators of inflammation and cell death;Jiménez Fernández;Biol. Chem,2015

4. Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme;Yamin;J. Biol. Chem,1996

5. Structure and mechanism of interleukin-1 β converting enzyme;Wilson;Nature,1994

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What are NLRP3-ASC specks? an experimental progress of 22 years of inflammasome research;Frontiers in Immunology;2023-07-26

2. Oligomeric states of ASC specks regulate inflammatory responses by inflammasome in the extracellular space;Cell Death Discovery;2023-04-29

3. MicroRNA-122a aggravates intestinal ischemia/reperfusion injury by promoting pyroptosis via targeting EGFR-NLRP3 signaling pathway;Life Sciences;2022-10

4. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma;Frontiers in Immunology;2022-08-03

5. The TLR‐chaperone CNPY3 is a critical regulator of NLRP3‐inflammasome activation;European Journal of Immunology;2022-04-07